INIS
kazakhstan
100%
epidemiology
100%
data
87%
patients
78%
diseases
62%
mortality
51%
children
50%
pediatrics
50%
reviews
35%
diabetes mellitus
34%
risks
34%
kidneys
33%
populations
25%
cardiovascular diseases
22%
comparative evaluations
20%
dialysis
18%
therapy
17%
death
17%
hospitals
16%
asthma
16%
malignancies
16%
nutrition
16%
juveniles
16%
arthritis
16%
ischemia
16%
management
16%
males
15%
sex
12%
females
11%
hazards
10%
leukemia
10%
lymphomas
10%
regression analysis
9%
age groups
8%
neoplasms
7%
arteries
7%
coronaries
7%
screening
6%
clinical trials
6%
Keyphrases
Kazakhstan
66%
Epidemiology
50%
Electronic Health Systems
41%
Diabetes
33%
Type 1 and Type 2 Diabetes Mellitus
33%
High Risk
23%
Incidence Rate
20%
Hospital Incidence
16%
Asthma children
16%
Population-based Retrospective Cohort Study
16%
All-cause Mortality
16%
Cardiovascular Disease
16%
Pediatric nutrition
16%
Biostatistics
16%
Diabetes Epidemiology
16%
Systemic Juvenile Idiopathic Arthritis (sJIA)
16%
Rheumatic Disorders
16%
Celiac Disease
16%
Dialysis Patients
16%
Dialysis
16%
European Associations
16%
End-stage Renal Disease Patients
16%
Pediatric
16%
Pediatric Hematological Malignancies
16%
Actovegin
16%
Mortality Outcomes
16%
Scottish
16%
Asthma
16%
Hospital Admission
16%
Mortality Rate
15%
Kazakh
13%
Hospitalization Risk
12%
Age Groups
12%
Prevalence Rate
11%
Kazakh Population
9%
Comorbidity
9%
Type 1 Diabetes Mellitus (T1DM)
8%
Risk of Death
8%
Confidence Interval
8%
Older Patients
8%
End-stage Renal Disease
8%
Survival Probability
8%
Young Ones
8%
Administrative Healthcare Data
6%
Cardiovascular Disease Incidence
6%
Primary Kidney Disease
6%
Neoplasms
5%
Diabetic Nephropathy
5%
Male Sex
5%
Old Age
5%
Medicine and Dentistry
Cohort Effect
83%
Health System
38%
Pediatrics
33%
Maturity Onset Diabetes of the Young
33%
Diabetes
33%
Prevalence
27%
All Cause Mortality
26%
Mortality Rate
21%
Cause of Death
19%
Coeliac Disease
16%
Biostatistics
16%
Juvenile Idiopathic Arthritis
16%
Epidemiology of Diabetes
16%
Rheumatic Disorder
16%
End Stage Renal Disease
16%
Cardiovascular Disease
16%
Hematologic Malignancy
16%
Actovegin
16%
Child Nutrition
16%
Survival Rate
11%
Leukemia
10%
Coronary Artery Disease
9%
Neoplasm
9%
Diabetic Nephropathy
9%
Apoplexy
9%
Amputation
9%
Proportional Hazards Model
8%
Acute Myelogenous Leukemia
6%
Insulin Dependent Diabetes Mellitus
6%
Peritoneal Dialysis
5%
Hemodialysis
5%
Renal Replacement Therapy
5%
